Clinical trial
VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated…
NCT00394823 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00394823 |
|---|---|
| Title | VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients |
| Official title | A Randomized, Open-label, Multicentric Parallel Group Study to Assess the Impact of Supportive Measures on the Drug Adherence of Patients With Essential Hypertension Treated With Valsartan or Valsartan Plus HCTZ for 34 Weeks With or Without Respective Measures |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Behavioral |
| Interventions | Set of supportive tools/measures vs. standard care |
| Enrollment | 206 |
| Start date | Nov 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Nov 1, 2006 |
| Last update posted | May 18, 2017 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: